GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cano Health Inc (OTCPK:CANOQ) » Definitions » EV-to-EBITDA

Cano Health (Cano Health) EV-to-EBITDA : -1.53 (As of Apr. 28, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Cano Health EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Cano Health's enterprise value is $1,222 Mil. Cano Health's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-799 Mil. Therefore, Cano Health's EV-to-EBITDA for today is -1.53.

The historical rank and industry rank for Cano Health's EV-to-EBITDA or its related term are showing as below:

CANOQ' s EV-to-EBITDA Range Over the Past 10 Years
Min: -186.62   Med: -2.68   Max: 279.83
Current: -1.53

During the past 5 years, the highest EV-to-EBITDA of Cano Health was 279.83. The lowest was -186.62. And the median was -2.68.

CANOQ's EV-to-EBITDA is ranked worse than
100% of 462 companies
in the Healthcare Providers & Services industry
Industry Median: 12.98 vs CANOQ: -1.53

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-28), Cano Health's stock price is $0.2708. Cano Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-340.427. Therefore, Cano Health's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Cano Health EV-to-EBITDA Historical Data

The historical data trend for Cano Health's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cano Health EV-to-EBITDA Chart

Cano Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
- - -186.66 -6.30 -1.32

Cano Health Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.30 -5.17 -3.04 -1.24 -1.32

Competitive Comparison of Cano Health's EV-to-EBITDA

For the Medical Care Facilities subindustry, Cano Health's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cano Health's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cano Health's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Cano Health's EV-to-EBITDA falls into.



Cano Health EV-to-EBITDA Calculation

Cano Health's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=1222.002/-799.328
=-1.53

Cano Health's current Enterprise Value is $1,222 Mil.
Cano Health's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-799 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cano Health  (OTCPK:CANOQ) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Cano Health's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.2708/-340.427
=At Loss

Cano Health's share price for today is $0.2708.
Cano Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-340.427.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Cano Health EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Cano Health's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Cano Health (Cano Health) Business Description

Traded in Other Exchanges
N/A
Address
9725 NW 117th Avenue, Suite 200, Miami, FL, USA, 33178
Cano Health Inc operates value-based primary care centers and supports affiliated medical practices that specialize in primary care for seniors in Florida, Texas, Nevada, and Puerto Rico.
Executives
Elliot Cooperstone director, 10 percent owner C/O CANO HEALTH, INC., 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178
Eladio Gil officer: Interim CFO 9725 NW 17TH AVENUE, SUITE 200, MIAMI FL 33178
Robert Camerlinck officer: Chief Operating Officer 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178
Richard Aguilar officer: Chief Clinical Officer 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178
Mark D. Kent officer: Interim CEO 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178
David J Armstrong officer: See Remarks 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178
Brian D Koppy officer: Chief Financial Officer 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178
Lewis Gold director 1235 SPANISH RIVER ROAD, BOCA RATON FL 33432
Marlow Hernandez director, officer: See Remarks 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178
Solomon D Trujillo director 1000 NICOLLET MALL, TPS-3255, MINNEAPOLIS MN 55403
Alan Muney director 48 MONROE TURNPIKE, TRUMBULL CT 06611
Kim M Rivera director 601 HAWAII ST, EL SEGUNDO CA 90245
Itc Rumba, Llc 10 percent owner 444 MADISON AVENUE, 35TH FLOOR, NEW YORK NY 10022
Jacqueline Guichelaar director C/O CANO HEALTH, INC., 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178
Angel L Morales director C/O CANO HEALTH, INC., 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178